thrives afterwards. Performance Summary Consolidated Statement of Comprehensive Income Note: (1) Excluded unrealized gain from foreign exchange rate on convertible bond, gain from fair value adjustment on
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
-1 -Translation- Ref. LPN/SorKor/146/2562 9th May 2019 Re: Financial Statements Analysis Report Q1/2019 Dear: President The Stock Exchange of Thailand L.P.N. Development Public Co.,Ltd. would like to
June 30, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For six months ended June 30, 2019 Overall Group Performance Table 1
Management Discussion and Analysis 1 Ref: AC.017/2020 18 May 2020 Subject: Management discussion and analysis of financial position and operating results To: President and Manager The Stock Exchange
explanation and analysis Quarter 1/2021 ending 31 March 2021 Attention: The President of, The Stock Exchange of Thailand Ziga Innovation Public Company Limited (“the Company”) manufactures and distributes Pre
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting